Authors:
CLAYE LH
AKUNNE HC
DAVIS MD
DEMATTOS S
SOLIMAN KFA
Citation: Lh. Claye et al., BEHAVIORAL AND NEUROCHEMICAL CHANGES IN THE DOPAMINERGIC SYSTEM AFTERREPEATED COCAINE ADMINISTRATION, Molecular neurobiology, 11(1-3), 1995, pp. 55-66
Citation: Ds. Fong et al., SUBRETINAL FIBROSIS IN PATIENTS WITH DIABETIC-RETINOPATHY, Investigative ophthalmology & visual science, 36(4), 1995, pp. 819-819
Authors:
MARTIN DF
PARKS DJ
MELLOW SD
FERRIS FL
WALTON RC
REMALEY NA
CHEW EY
ASHTON P
DAVIS MD
NUSSENBLATT RB
Citation: Df. Martin et al., TREATMENT OF CYTOMEGALOVIRUS RETINITIS WITH AN INTRAOCULAR SUSTAINED-RELEASE GANCICLOVIR IMPLANT - A RANDOMIZED CONTROLLED CLINICAL-TRIAL, Investigative ophthalmology & visual science, 36(4), 1995, pp. 820-820
Authors:
BIRD AEC
BRESSLER NM
BRESSLER SB
CHISHOLM IH
COSCAS G
DAVIS MD
DEJONG PTVM
KLAVER CCW
KLEIN BEK
KLEIN R
MITCHELL P
SARKS JP
SARKS SH
SOURBANE G
TAYLOR HR
VINGERLING JR
Citation: Aec. Bird et al., AN INTERNATIONAL CLASSIFICATION AND GRADING SYSTEM FOR AGE-RELATED MACULOPATHY AND AGE-RELATED MACULAR DEGENERATION, Survey of ophthalmology, 39(5), 1995, pp. 367-374
Authors:
PUGSLEY TA
DAVIS MD
AKUNNE HC
MACKENZIE RG
SHIH YH
DAMSMA G
WIKSTROM H
WHETZEL SZ
GEORGIC LM
COOKE LW
DEMATTOS SB
CORBIN AE
GLASE SA
WISE LD
DIJKSTRA D
HEFFNER TG
Citation: Ta. Pugsley et al., NEUROCHEMICAL AND FUNCTIONAL-CHARACTERIZATION OF THE PREFERENTIALLY SELECTIVE DOPAMINE D3 AGONIST PD-128907, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1355-1366
Citation: Ta. Pugsley et al., CI-1007, A DOPAMINE PARTIAL AGONIST AND POTENTIAL ANTIPSYCHOTIC AGENT.1. NEUROCHEMICAL EFFECTS, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 898-911
Authors:
QUINN TC
JABS DA
HOLBROOK JT
HARDY WD
POLSKY B
LEWIS RA
CLOGSTON P
FAINSTEIN V
GROSS R
SAMO T
TUTTLE C
APUZZO L
BARTLETT J
DUNN JP
ELDRED L
FEINBERG J
FLYNN T
KING R
BARRON B
GREENSPAN D
LECOUNT C
PEYMAN G
FRANKLIN R
HEINEMANN M
SQUIRES K
WISECAMPBELL S
FRIEDMAN AH
CHEUNG TW
JUSTIN N
TEICH SA
SACKS H
SEVERIN C
FRIEDBERG DN
ADDESSI A
DIETERICH D
LAFLEUR F
WEINBERG D
JAMPOL L
MURPHY R
NAUGHTON K
HENDERLY D
HOLLAND GN
CHAFEY S
FALL H
KIMBRELL C
MACARTHUR LJ
FREEMAN WR
MEIXNERT L
PETERSON TJ
QUICENO JI
RICKMAN L
SIMANELLO MA
SPECTOR S
ODONNELL J
HOFFMAN J
IRVINE A
JACOBSON M
LARSON J
SEIFF S
WARNER L
DAVIS J
CHUANG E
ESPINAL M
MENDEZ P
CHEESEMAN SH
GITTINGER J
HAUBRICH R
KACHADOORIAN H
TOLSON K
BROWNBELLAMY J
KLEMM AC
MARKOWITZ JA
MEINERT CL
AMENDLIBERCCI A
COLESON L
COLLINS KL
COLLISON BJ
DODGE J
DONITHAN M
EWING C
FINK N
GERCZAK C
ISAACSON MR
KAPLANGILIPIN A
HUFFMAN R
LEVINE CR
NOWAKOWSKI DJ
SMITH M
TONASCIA J
VANNATTA ML
AGRESSEGAL M
ARMSTRONG J
BROTHERS R
HUBBARD L
HURLBURT D
MAGLI Y
MINER K
THOMAS S
VANDERHOOFYOUNG M
STEWART G
HUGHES R
LEEF J
PALMER S
MOWERY R
ELLENBERG S
KORVICK J
DAVIS MD
CLARK T
MERIN L
SATTLER F
JORDAN C
MILLS J
BROWN BW
CONWAY B
GRIZZLE J
NUSSENBLATT R
PHAIR J
SMITH H
KLINE R
MOSS M
CARELLA A
Citation: Tc. Quinn et al., ANTIVIRAL EFFECTS OF FOSCARNET AND GANCICLOVIR THERAPY ON HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN IN PATIENTS WITH AIDS AND CYTOMEGALOVIRUS RETINITIS, The Journal of infectious diseases, 172(3), 1995, pp. 613-621
Authors:
LEWIS RA
CLOGSTON P
FAINSTEIN V
GROSS R
SAMO T
TUTTLE C
JABS DA
APUZZO L
BARTLETT J
COLESON L
DUNN JP
ELDRED L
FEINBERG J
FLYNN T
KING R
LESLIE J
BARRON B
GREENSPAN D
LECOUNT C
PEYMAN G
FRANKLIN R
HEINEMANN MH
POLSKY B
SQUIRES K
WISECAMPBELL S
FRIEDMAN AH
CHEUNG TW
JUSTIN N
TEICH S
SACKS H
SEVERIN C
FRIEDBERG DN
ADDESSI A
DIETERICH D
FROST K
WEINBERG D
JAMPOL L
MURPHY R
NAUGHTON K
HENDERLY D
HOLLAND GN
CHAFEY S
FALL H
HARDY WD
KIMBRELL C
MACARTHUR LJ
FREEMAN WR
MEIXNERT L
PETERSON TJ
QUICENO JI
RICKMAN L
SIMANELLO MA
SPECTOR S
ODONNELL J
HOFFMAN J
IRVINE A
JACOBSON M
LARSON J
SEIFF S
WANNER M
DAVIS J
CHUANG E
ESPINAL M
MENDEZ P
VANDENBROUCKE R
CHEESEMAN SH
GITTINGER J
HAUBRICH R
KACHADOORIAN H
TOLSON K
KLINE JM
KLEMM AC
STEVENS M
WEBB R
BROWNBELLAMY J
MARKOWITZ JA
MEINERT CL
BINDER KL
BROOKMEYER R
BROWN VE
COLLISON BJ
DODGE J
DONITHAN M
FINK N
GERCZAK C
HOLBROOK JT
ISAACSON MR
JONES CP
LEVINE CR
MIN YI
MEINERT JL
OWENS RM
NOWAKOWSKI DJ
SAAH A
SANDFORD GR
SINGER S
SMITH M
STERNBERG AL
TONASCIA J
VANNATTA ML
DAVID MD
AGRESSEGAL M
ARMSTRONG J
BROTHERS R
FREITAG G
HUBBARD L
HURLBURT D
KASTORFF L
MAGLI Y
MINER K
THOMAS S
VANDERHOOFYOUNG M
STEWART G
HUGHES R
WELCH L
MOWERY R
ELLENBERG S
KORVICK J
DAVIS MD
CLARK T
CLOGSTON PS
FREEMAN W
SATTLER F
JORDAN C
MILLS J
BROWN BW
CONWAY B
GRIZZLE J
NUSSENBLATT R
PHAIR J
SMITH H
Citation: Ra. Lewis et al., MORBIDITY AND TOXIC EFFECTS ASSOCIATED WITH GANCICLOVIR OR FOSCARNET THERAPY IN A RANDOMIZED CYTOMEGALOVIRUS RETINITIS TRIAL, Archives of internal medicine, 155(1), 1995, pp. 65-74
Authors:
HEYL DL
SEFLER AM
HE JX
SAWYER TK
WUSTROW DJ
AKUNNE HC
DAVIS MD
PUGSLEY TA
HEFFNER TG
CORBIN AE
CODY WL
Citation: Dl. Heyl et al., STRUCTURE-ACTIVITY AND CONFORMATIONAL STUDIES OF A SERIES OF MODIFIEDC-TERMINAL HEXAPEPTIDE NEUROTENSIN ANALOGS, International journal of peptide & protein research, 44(3), 1994, pp. 233-238
Authors:
BROWN RH
LYNCH M
LEEF D
GUNSBY J
LOBER K
MOORE K
STEPKA C
VELATHOMAS A
GAASTERLAND DE
COYLE E
HUNDLEY M
ASHBURN F
VAYER L
MICHELITSCH K
LAUBER S
BURT E
RAE A
WEBER PA
DERICK R
MCKINNEY K
MOORE D
BAKER ND
KAPETANSKY F
LEHMAN D
GLOECKNER B
SHARF LJ
ROMANS B
SATTERWHITE Y
SIMMONS L
HARBIN TS
OZMENT RR
WRIGHT J
BUTLER L
LASALLE J
PERRY M
NUMMERDOR D
WILLE L
ECKEL A
SESSION C
MARTIN A
CYRLIN MN
FAZIO R
WILENSKY JT
LINDENMUTH K
NAIL CA
RATHBONE D
GATES V
TADELMAN M
SONTY S
HOPKINS G
HIGGINBOTHAM EJ
SCHOLES G
UVA R
PAPPAS L
FROHLICHSTEIN D
FIENE J
BERGSTROM TJ
LICHTER PR
STANDARDI C
ZIEHMSCOTT J
PAPIERNIAKDUBIEL R
POLLACKRUNDLE C
SKUTA GL
BEESON C
CREW RP
KRUSEKE L
MICHAEL B
DEDERIAN J
WICKER D
AARON D
BIRK J
VANHECK T
ALLEN RC
NEWMAN SA
NORLUND JR
FENDLEY CK
BERGHUIS C
CHISHOLM J
EVANS C
MURPHY E
SCHOTT LJ
FORNILI R
SCHWARTZ AL
WEISS H
WEHRLY S
PAPPAS S
ODEA M
BOECKL A
LOPEZ P
CARMODY K
MERCER R
MONKS V
VAWTER K
WITOL CV
CIRONE M
GURLEY J
REED C
BROWNING J
HARRIS E
KATZ LJ
SPAETH GL
WILSON RP
SAMUEL F
BLOCK A
KAO S
BEKERSHOFF CC
CAPRIOLI J
MILLER E
ROCHE M
GROTTOLE G
LEONE A
TRESSLER C
EDERER F
SULLIVAN EK
WAGNER EL
ENTLER G
BRADFORD M
TOMLIN KL
STINE E
LINDBLAD AS
KNOKE JD
DENEKAS M
SMITH C
VOSS T
MOWERY RL
LYNCH G
GOFF F
FURBERG CD
CONNETT JE
DAVIS MD
DUEKER DK
GREEN SB
HAMILTON MP
SCHNEIDERMAN MA
KASSOFF A
MORRIS M
PALMBERG PF
Citation: Rh. Brown et al., THE ADVANCED GLAUCOMA INTERVENTION STUDY (AGIS) .1. STUDY DESIGN AND METHODS AND BASE-LINE CHARACTERISTICS OF STUDY PATIENTS, Controlled clinical trials, 15(4), 1994, pp. 299-325
Citation: Ds. Fong et al., A POORLY RECOGNIZED CAUSE OF SEVERE VISUAL-LOSS IN DIABETICS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1749-1749
Authors:
MARTIN DF
PARKS DJ
MELLOW SD
FERRIS FL
CHEW EY
WALTON RC
ANAND R
ASHTON P
DAVIS MD
NUSSENBLATT RB
Citation: Df. Martin et al., THE GANCICLOVIR IMPLANT FOR CYTOMEGALOVIRUS RETINITIS - A RANDOMIZED,CONTROLLED CLINICAL-TRIAL, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1893-1893
Citation: Ba. Citron et al., ELECTROSTATIC ACTIVATION OF RAT PHENYLALANINE-HYDROXYLASE, Biochemical and biophysical research communications, 198(1), 1994, pp. 174-180
Authors:
MARTIN DF
PARKS DJ
MELLOW SD
FERRIS FL
WALTON RC
REMALEY NA
CHEW EY
ASHTON P
DAVIS MD
NUSSENBLATT RB
Citation: Df. Martin et al., TREATMENT OF CYTOMEGALOVIRUS RETINITIS WITH AN INTRAOCULAR SUSTAINED-RELEASE GANCICLOVIR IMPLANT - A RANDOMIZED CONTROLLED CLINICAL-TRIAL, Archives of ophthalmology, 112(12), 1994, pp. 1531-1539
Citation: Md. Davis, CHARACTERIZATION OF EARLY STAGES OF DIABETIC-RETINOPATHY - IMPORTANCEOF THE BREAKDOWN OF THE BLOOD-RETINAL BARRIER, Diabetes care, 16(8), 1993, pp. 1213-1214
Citation: Rw. Connell et al., A BASTARD OF A LIFE - HOMOSEXUAL DESIRE AND PRACTICE AMONG MEN IN WORKING-CLASS MILIEUS, Australian and New Zealand journal of sociology, 29(1), 1993, pp. 112-135
Citation: Md. Davis et S. Kaufman, PRODUCTS OF THE TYROSINE-DEPENDENT OXIDATION OF TETRAHYDROBIOPTERIN BY RAT-LIVER PHENYLALANINE-HYDROXYLASE, Archives of biochemistry and biophysics, 304(1), 1993, pp. 9-16
Authors:
CITRON BA
KAUFMAN S
MILSTIEN S
NAYLOR EW
GREENE CL
DAVIS MD
Citation: Ba. Citron et al., MUTATION IN THE 4A-CARBINOLAMINE DEHYDRATASE GENE LEADS TO MILD HYPERPHENYLALANINEMIA WITH DEFECTIVE COFACTOR METABOLISM, American journal of human genetics, 53(3), 1993, pp. 768-774
Citation: Md. Davis, VIGNOLA,JACOPO, MANZUOLI,ALESSANDRO AND T HE VILLA-ISOLANI IN MINERBIO - VIGNOLA EARLY STUDIES OF CLASSICAL-ARCHITECTURE, Mitteilungen des Kunsthistorischen Institutes in Florenz, 36(3), 1992, pp. 287-328